In summary, IL-6, VCAM-1, IL-8, and CXCL10 are potentially inflammatory diagnostic biomarkers for NASH, but these biomarkers are not disease-specific and may be disturbed by systemic inflammation, so a comprehensive clinical judgment is needed. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatohepatitis.